MoonLake Immunotherapeutics (MLTX) Sector Health Care
(Current)
$45.70 -0.93 (-1.99%)
Open Price: 43.65
MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company unlocking the potential of Sonelokimab, the novel investigational Nanobody® for the treatment of inflammation, to revolutionize outcomes for patients